Feds Fight Convicted Ex-Valeant Exec's Claims Of Juror Bias

By Dean Seal · June 20, 2018, 7:18 PM EDT

Prosecutors told a New York federal court Tuesday that a former Valeant Pharmaceuticals International Inc. manager's conviction over a $9.7 million kickback plot can't be scrapped just because one of the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Letter Response

Case Information

Case Title

USA v. Tanner et al

Case Number

Court

New York Southern

Nature of Suit

Date Filed

January 26, 2017

Recent Articles By Dean

March 29, 2022
JPMorgan And Wells Fargo Dodge Flint Water Crisis Claims
February 08, 2022
Court Boots Mootness Fee Bid In Microsoft Merger Challenge
January 10, 2022
SPAC Investor Says Talkspace Misled On Costs, Demand
September 01, 2021
Another Federal Judge Tosses An Investor Suit Over Diversity
August 24, 2021
SEC Nabs $6M Settlement In Earnings Management Sweep
June 10, 2021
2 Israeli Traders Charged In Global Insider Trading Ring
April 16, 2021
Ex-Katten Atty's Retirement Accounts Can Be Garnished
March 15, 2021
Biotech Co. Says It Never Lied About Its COVID Vaccine Work
March 11, 2021
Why A Surge Of COVID Securities Suits Hasn't Happened
October 14, 2020
SEC Seeks To Restore Judgment Nixed By 9th Circ. Over Liu